clenbuterol has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Neill, E | 1 |
| Yssel, JD | 1 |
| McNamara, C | 1 |
| Harkin, A | 1 |
1 other study available for clenbuterol and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Pharmacological targeting of β
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Animals; Anti-Inflammatory Agents | 2020 |